Breadcrumb

About

The RNA Biology Laboratory was formed in 2017 to enhance RNA research at the NCI. Our mission is to carry out cutting-edge research into the roles of RNAs and RNA-protein complexes in cancer and to foster synergistic interactions and cross-disciplinary collaborations between a wide range of RNA scientists and clinicians. Areas under study include the pathways by which RNAs are synthesized, processed and degraded, the mechanisms by which noncoding RNAs and RNA-protein complexes contribute to cell function, the ways in which alterations in RNA metabolism contribute to human cancers, and the development of RNA-based therapies.

Noncoding RNAs & RNPs Section: Dr. Sandra Wolin studies how noncoding RNAs function, how cells recognize and degrade defective RNAs, and how failure to degrade these RNAs affects cell function and contributes to human disease.

Functional Transcriptomics Section: Dr. Thomas Gonatopoulos-Pournatzis studies the impact of post-transcriptional regulation on cell fate decisions and how disruption of pre-mRNA processing contributes to cancer and neurodevelopmental disorders by applying functional genomics approaches.

RNA Mediated Gene Regulation Section: Dr. Shuo Gu focuses on mechanisms of RNA interference, the pathways by which microRNAs are synthesized and degraded and the applications of microRNAs in cancer treatment.  Areas of particular interest include the fidelity of microRNA processing and the cellular roles of microRNA modifications.

Molecular Mechanisms of Transcription Section: Dr. Mikhail Kashlev studies how RNAs are synthesized. He conducts biochemical and genetic studies of the mechanisms regulating transcription elongation and RNA polymerase fidelity in E. coli, yeast and mammalian cells.  They also investigate the impact of transcription errors in cancer, and study transcription-coupled DNA repair in yeast and mammalian cells.

Messenger RNA Regulation and Decay Section: Dr. Eugene Valkov focuses on structural and biochemical characterization of the messenger RNA degradation machinery and how decay factors interface mechanistically with other post-transcriptional processes such as translational repression and regulation.

Translational Control of Gene Expression Section: Dr. Colin Wu is interested in understanding the molecular mechanisms of ribosome-mediated translational regulation by ribosome-associated factors and RNA binding proteins. They are also pursuing non-canonical roles of the ribosome in dictating life-or-death cell fate decisions in response to cellular stress in mammalian cells.

Job Vacancies

Position Degree Required Contact Name Contact Email
Senior Investigator - RNA biology Ph.D. or equivalent, M.D. or equivalent Patrick Miller millerp@mail.nih.gov
Post-doctoral Fellow - Alternative splicing regulation, functional genomics, CRISPR-Cas Ph.D. or equivalent Thomas Gonatopoulos-Pournatzis thomas.gonatopoulos@nih.gov

Contact

Contact Info

Center for Cancer Research National Cancer Institute

  • Building 560, Room 11-82
  • Frederick, MD 21702-1201
  • 301-846-1225
Angela Escalante
Secretary
Angela Escalante
Patti Lamb
Secretary
Patti Lamb
Michael Bonaduce
Technical Lab Manager
Michael Bonaduce
Picture of Jenny Miller
Technical Lab Manager
Jennifer Miller